Voyager Therapeutics’ (VYGR) Buy Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a report released on ...
Voyager Therapeutics, Inc. (NASDAQ:VYGR) Receives $15.72 Average Price Target from Analysts
Voyager Therapeutics, Inc. (NASDAQ:VYGR – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ...
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today ...
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), Senseonics Holdings (SENS) and Voyager Therapeutics (VYGR)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Elanco Animal Health (ELAN – Research ...
Morningstar6d
Voyager Therapeutics Announces Fourth Quarter 2024 Conference Call and Webcast
LEXINGTON, Mass., March 04, 2025 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced it will ...
Zacks Investment Research on MSN3d
CytomX Therapeutics (CTMX) Tops Q4 Earnings and Revenue Estimates
CytomX Therapeutics (CTMX) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of a loss of $0.20 per share. This compares to earnings of $0.01 per share a year ...
Zacks Investment Research on MSN5d
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Lags Revenue Estimates
TScan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.29 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.21 per share a year ago. These ...
Yahoo Finance5d
Voyager Therapeutics, Inc. (VYGR)
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.